Filing Flows

Filing Flows › Materials › Aemetis (AMTX)

Aemetis (AMTX) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Aemetis (AMTX) Q3 2026 earnings results →

Q3 2026 Revenue up 49% year over year to $88.2M · 6¢ of every $1 of revenue kept as net profit · operating margin 23.7%

Aemetis made $88.2M in Q3 2026 (+49% Y/Y): California Ethanol $53.8M, California Dairy Renewable Natural Gas $25.9M, India Biodiesel Segment $8.4M. Operating margin 23.7%, net earnings $5.2M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$88.2M
Year over year+49%
Operating margin23.7%
Net earnings$5.2M
Operating cash flow$22.0M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $88.2M in Q3 2026, up 49% year over year and up 41% from the previous quarter. California Ethanol was the largest line at 61% of revenue. California Dairy Renewable Natural Gas added $21.9M year over year (up 549%), 76% of the total change. India Biodiesel Segment declined 42%.

Gross margin was 33.4%. Operating profit was $20.9M, a 23.7% margin (up 38.0 points year over year). Net earnings were $5.2M. The effective tax rate was 0.0%.

Operating cash flow was $22.0M (up 616% year over year), 421% of net earnings. Non-cash charges added back $2.6M of depreciation and amortization and $1.2M of share-based compensation. Working capital and other items added $13.0M. Capital expenditures of $20.2M left free cash flow of $1.7M.

Quarterly history

Aemetis revenue by quarterAemetis revenue by quarter$42.9MQ1 2025$52.2MQ2 2025$59.2MQ3 2025$43.3MQ4 2025$54.6MQ1 2026$62.7MQ2 2026$88.2MQ3 2026
Aemetis net earnings by quarterAemetis net earnings by quarter−$24.5MQ1 2025−$23.4MQ2 2025−$23.7MQ3 2025−$5.3MQ4 2025−$21.7MQ1 2026−$9.4MQ2 2026$5.2MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 5, 2026$88.2M+49%23.7%$5.2M$22.0M
Q2 202610-QAug 6, 2026$62.7M+20%9.2%−$9.4M−$1.9M
Q1 202610-QMay 7, 2026$54.6M+27%-11.6%−$21.7M−$10.6M
Q4 202510-KMar 16, 2026$43.3M-8%-5.7%−$5.3M$5.8M
Q3 202510-QNov 7, 2025$59.2M-27%-14.4%−$23.7M$3.1M
Q2 202510-QAug 7, 2025$52.2M-22%-20.4%−$23.4M−$5.7M
Q1 202510-QMay 8, 2025$42.9M-41%-36.3%−$24.5M$160K

Charts

Aemetis: revenue growth, year over year and quarter over quarterAemetis: revenue growth, year over year and quarter over quarterY/YQ/Q-41%Q1 2025-22%+22%Q2 2025-27%+13%Q3 2025-8%-27%Q4 2025+27%+26%Q1 2026+20%+15%Q2 2026+49%+41%Q3 2026
Latest (Q3 2026): Y/Y +49%, Q/Q +41%.
Aemetis: where the cash came from (+) and went (−), TTM to Q3 2026Aemetis: where the cash came from (+) and went (−), TTM to Q3 2026Net borrowing (+) / repaid (−)$53.0MCapital spending−$51.9MOther financing−$39.6MShares issued$18.1MOperating cash flow$15.3MCash drawn (+) / kept (−)$3.7MOther investing$1.4MExchange rates$62K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Aemetis: profit against cash, quarter by quarterAemetis: profit against cash, quarter by quarterNet incomeOperating cash flow−$16.2M−$12.6MQ4 2024−$24.5M$160KQ1 2025−$23.4M−$5.7MQ2 2025−$23.7M$3.1MQ3 2025−$5.3M$5.8MQ4 2025−$21.7M−$10.6MQ1 2026−$9.4M−$1.9MQ2 2026$5.2M$22.0MQ3 2026
Latest (Q3 2026): Net income $5.2M, Operating cash flow $22.0M.
Aemetis: diluted shares by fiscal yearAemetis: diluted shares by fiscal year21MFY202031MFY202135MFY202238MFY202346MFY202460MFY2025
+185.5% since FY2020: more shares outstanding (issuance, stock pay).
Aemetis in its industry: growth against margin (19 companies, SIC 2860)Aemetis in its industry: growth against margin (19 companies, SIC 2860)revenue growth, year over year →↑ operating marginmedian +6%median 13%LYBWLKIFFUnion Carbide CorpNEUGPRESXTWLKPALTOREXFFGEVOHighwater Ethanol LLCCDXSLNZATOMZSAFXLODEAMTX (+49%, 24%)
Industrial Organic Chemicals; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Aemetis

Founded in 2006 and headquartered in Cupertino, California, Aemetis, Inc. (collectively with its subsidiaries on a consolidated basis referred to herein as “Aemetis,” the “Company,” “we,” “our” or “us”) is an international renewable natural gas and renewable fuels company focused on the operation, acquisition, development, and commercialization of innovative technologies to produce low and negative carbon intensity renewable fuels that lower fuel costs and reduce emissions. We do this by building a local circular bioeconomy using agricultural products and wastes to produce low carbon, advanced renewable fuels that reduce greenhouse gas ("GHG") emissions and improve air quality. Our current operations include:

In its own words, from its 10-K, filed Mar 16, 2026.

Aemetis against its Industrial Organic Chemicals peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +49% against the peers' median +5%. Operating margin: 23.7% against the peers' median 18.7%.

CompanyQuarterRevenueY/YOp. margin
AMTX AemetisQ3 2026$88.2M+49%23.7%
LYB LyondellBasell Industries N.V.Q3 2026$8.5B+10%12.6%
WLK WestlakeQ3 2026$3.0B+5%1.4%
IFF International Flavors & FragrancesQ3 2026$1.9B+4%8.2%
Union CarbideQ3 2026$1.5B+38%29.6%
NEU NewmarketQ3 2026$717M+4%20.0%
GPRE Green PlainsQ3 2026$496M-2%18.7%
SXT Sensient TechnologiesQ3 2026$456M+11%15.9%
WLKP Westlake Chemical Partners LPQ3 2026$314M+2%30.4%

Source: Aemetis 10-Q on SEC EDGAR · CIK 738214 · Industrial Organic Chemicals

Guidance and outlook

Aemetis: what its forward-looking statements are about (10-Q filed 2026-11-05)Aemetis: what its forward-looking statements are about (10-Q filed 2026-11-05)Other5Demand4Costs1Margins1Financing1
12 statements; tone -0.08 (−1 all cautious, +1 all confident); 1 hedged.
Aemetis: outlook statements against the filing beforeAemetis: outlook statements against the filing beforeCautious1

13F: who owns AMTX and who is buying

Largest holders of AMTX (13F)Largest holders of AMTX (13F)BlackRock$6.5MVanguard Capital Management LLC$4.9MVanguard Group$4.1MGeode Capital Management, LLC$2.8MGrantham, Mayo, Van Otterloo & Co…$1.7MState Street$1.2MD. E. Shaw$1.0MNorthern Trust$833KVanguard Portfolio Management LLC$725KVanguard Fiduciary Trust$720K
Funds' net buying of AMTX by quarter (13F)Funds' net buying of AMTX by quarter (13F)$54K2024-09$258K2024-12−$1.4M2025-03−$3.6M2025-06$1.1M2025-09$29K2025-12$7.1M2026-03$7.8M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on AMTX

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare AMTX with

中文版:Aemetis(AMTX)财报

Español · Français